2 hours ago
1
Dzmitry Skazau/iStock via Getty Images
Shares of Soleno Therapeutics (NASDAQ:SLNO) fell on Wednesday after a federal database indicated that a 17-year-old male treated with the company’s recently launched rare disease therapy Vykat XR had died.
The report comes months after the Redwood City, California-based biotech launched
English (US) ·